Toll-Like Receptor 4 Mediated Inflammation in Metabolic Disorders

Toll-like receptor 4 (TLR4) is a key sentinel of the innate immune system that recognises both microbial lipopolysaccharide (LPS) and certain saturated fatty acids, linking nutrient excess to chronic low-grade inflammation. In obesity and related metabolic disorders, elevated circulating LPS and free fatty acids activate TLR4 in adipocytes, macrophages, hepatocytes and endothelial cells, triggering intracellular cascades such as NF-κB and JNK. This sustained activation promotes production of pro-inflammatory cytokines, impairs insulin signalling and contributes to insulin resistance, type 2 diabetes and cardiovascular complications. Crosstalk between TLR4 and other receptors further amplifies inflammatory loops in adipose tissue and vasculature. Understanding the molecular details of TLR4 activation by endogenous ligands has revealed novel intervention points, from blocking receptor co-factors to modulating downstream effectors, offering potential strategies to restore metabolic homeostasis and prevent long-term sequelae of metabolic syndrome.

Research from Nature Portfolio

Recent work has elucidated a direct mechanism by which the predominant circulating saturated fatty acid, palmitic acid, binds to the TLR4 co-receptor MD2, thereby instigating receptor dimerisation and downstream inflammatory signalling. Experiments in MD2-deficient mice demonstrated protection against palmitate- and high-fat diet-induced cardiac injury, underlining MD2 as a critical mediator of TLR4-driven inflammation in obesity. Structural and biophysical studies confirmed direct fatty acid–MD2 interactions, consolidating the view that metabolic ligands can serve as bona fide TLR4 agonists. These findings open avenues for small-molecule inhibitors targeting the MD2–fatty acid interface to mitigate metaflammation in cardiometabolic disease.

Toll-Like Receptor 4 Mediated Inflammation in Metabolic Disorders publication trend

The graph below shows the total number of articles in toll-like receptor 4 mediated inflammation in metabolic disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Toll-like receptor 4 (TLR4): A pattern-recognition receptor of the innate immune system that senses lipopolysaccharide and certain fatty acids to initiate pro-inflammatory signalling.

MD2: A co-receptor protein that binds to TLR4 and is essential for ligand recognition and receptor activation.

NF-κB: A transcription factor that drives expression of pro-inflammatory cytokines following TLR4 activation.

Lipopolysaccharide (LPS): A component of Gram-negative bacterial cell walls and a canonical agonist of TLR4.

Long non-coding RNA (lncRNA): A class of RNA molecules >200 nucleotides in length that regulate gene expression without encoding proteins.

Peripheral blood mononuclear cells (PBMCs): A mixed population of lymphocytes and monocytes commonly used to study immune responses in human blood.

References

1. LncRNA LINK‐A Remodels Tissue Inflammatory Microenvironments to Promote Obesity. Advanced Science (2023).
2. Blocking Thromboxane-Prostanoid Receptor Signaling Attenuates Lipopolysaccharide- and Stearic Acid-Induced Inflammatory Response in Human PBMCs. Cells (2024).
3. Palmitate Stimulates Expression of the von Willebrand Factor and Modulates Toll-like Receptors Level and Activity in Human Umbilical Vein Endothelial Cells (HUVECs). International Journal of Molecular Sciences (2023).
4. Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nature Communications (2017).